B.Riley Starts Elicio Therapeutics (ELTX) at Buy
B.Riley analyst Mayank Mamtani initiates coverage on Elicio Therapeutics (NASDAQ: ELTX) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
